Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
Debt/EBITDA | 1.78 | 0.81 | -0.01 | -0.42 | -0.92 | -2.55 | ||
Changes by years, y/y, % | 0% | -55% | -101% | +4 630% | +122% |
Heron Therapeutics. Debt/EBITDA
Heron Therapeutics. Debt/EBITDA, changes, %
Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
Debt/EBITDA | -0.91 | -0.87 | -0.92 | -1.35 | -2.55 | -2.55 | ||
Changes by years, y/y, % | +165% | +397% | +119% | +99% | +182% | |||
Changes by quarters, q/q, % | +34% | -5% | +6% | +47% | +89% |